• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.04% Nasdaq Down 0.61%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    117.01 Down 3.27(2.72%) 3:11PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:120.28
    Open:120.72
    Bid:116.62 x 100
    Ask:116.76 x 100
    1y Target Est:127.21
    Beta:1.04
    Next Earnings Date:30-Apr-15BMRN Earnings announcement
    Day's Range:115.95 - 124.94
    52wk Range:55.36 - 133.54
    Volume:2,112,969
    Avg Vol (3m):1,516,960
    Market Cap:18.62B
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 2.72%18.62B
    FOLDDown 8.98%1.07B
    SHPGDown 2.23%48.79B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.31
    Quarterly EPS Est (Mar-15) :-0.53
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-2.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback